Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1520 of 6351
-
New heat therapy could free women from fibroid surgery
Disease control Not yet recruitingUterine fibroids are the most common benign tumors of the female genital tract and can significantly affect the quality of life in reproductive-age women, causing symptoms such as heavy menstrual bleeding, pelvic pressure, urinary disturbances, dyspareunia, and infertility. Tradi…
Sponsor: Jihad Hussien Mohamed Mahmoud • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
ER nurse chat could save babies from sleep death
Prevention Not yet recruitingThe sudden unexpected infant death (SUID) is defined as "the sudden death of a child aged from 1 month to 1 year who had been healthy until then, whereas nothing in his known history or in the history of events could have allowed him to predict". In France, the French High Autori…
Sponsor: University Hospital, Angers • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
Acupuncture needles join fight against lung cancer
Disease control Recruiting nowThe aim of this study was to systematically evaluate the clinical efficacy and safety of electroacupuncture (EA) combined with PD-1 inhibitors in patients with advanced non-small cell lung cancer (NSCLC) who have an ECOG performance status of 2 through a multicenter, randomized, …
Sponsor: Kong Fanming • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug aims to tackle diabetes by targeting stress hormone
Disease control Recruiting nowCAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors for trial eligibility and the presence of elevated cortisol. Participants deemed eligible from Part 1 will be randomized to either clofutrib…
Phase 2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
New Dual-Action drug targets Hard-to-Treat tumors
Disease control Recruiting nowStage 1 (Safety study for 68Ga-NRT6020 Injection): The goal of this clinical trial stage is to evaluate the safety of 68Ga-NRT6020 Injection in participants with advanced solid tumors. The study will also assess the biodistribution, radiation dosimetry, imaging profile, and phar…
Phase 1 • Sponsor: Chengdu New Radiomedicine Technology Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New HIV pill CL-197 shows promise in early trial for untreated patients
Disease control Recruiting nowThis study will evaluate the antiretroviral activity, safety and pharmacokinetics of single dose of CL-197 capsule in three dose groups administered to antiretroviral treatment-naïve adult participants with human immunodeficiency virus type 1 (HIV-1) infection.
Phase 2 • Sponsor: Henan Genuine Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Magnetic pulses to the brain may offer rapid relief from prolonged grief
Symptom relief Recruiting nowGrief is a normal response after the death of a loved one. With time, the grief response decreases and people learn to cope with their loss. However, for some, the response becomes more intense and distressing. This is called prolonged grief disorder (PGD). People with PGD experi…
Sponsor: Bruyère Health Research Institute. • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Scientists hunt for genetic clues behind rare blood disorders
Knowledge-focused Recruiting nowBy detailed sequence analysis and subsequent biophysical characterization of prototypic light chains, this project aims to identify sequence fingerprints in IGLV1-44 light chains leading to AL amyloidosis and POEMS syndrome. This understanding might help improve the risk stratifi…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New chemo combo targets cancer belly fluid in early trial
Disease control Recruiting nowThis study is a prospective, multi-cohort Phase Ib/II clinical trial, consisting of two stages as follows: 1. Phase Ib Dose-Escalation Stage To explore the dose-limiting toxicities (DLT) of intraperitoneally administered liposomal irinotecan in patients with malignant peritoneal…
Phase 1/2 • Sponsor: Dong sheng Zhang • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New hope for early MS: Twice-Yearly infusion trial launches
Disease control Recruiting nowIn this prospective, open-label, single-arm, single-institution trial, the investigators will accomplish the following two aims: 1. study the safety and tolerability of Ublituximab (Briumvi) twice annually in participants with early MS over a treatment observation period of \~12…
Phase 4 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New ultrasound technique could spot brain disorders in babies before symptoms appear
Knowledge-focused Recruiting nowNeurodevelopmental disorders (NDD) affect how the brain develops and can lead to lifelong difficulties with movement, learning, behavior, and thinking. Every year, around one million newborns in Europe are affected by these conditions. Some babies are at higher risk of NDD due to…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Could a gentle brain ZAP help ALS patients breathe easier?
Symptom relief Recruiting nowAmyotrophic Lateral Sclerosis (ALS) is a nervous system disease that causes muscle weakness and rapidly progresses to the loss of mobility and functionality. Studies suggest that High-Definition Transcranial Direct Current Stimulation (HD-tDCS) is a technique for modulating motor…
Phase 2/3 • Sponsor: Universidade Federal do Rio Grande do Norte • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Can tackling stigma help end HIV? new study tests a dual approach
Disease control OngoingThe overall goal of the Ssinga Nze study ("Ssinga Nze" means "If it were me" in Luganda, the local language) is to reduce HIV-related stigma and improve access to HIV care, including antiretroviral treatment (ART) and HIV pre-exposure prophylaxis (PrEP), as well as increase linka…
Sponsor: Makerere University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for kids with kidney disease: experimental drug aims to cut protein leak
Disease control Recruiting nowThe study is an open-label, single arm, multicenter, Phase III study to determine proteinuria reduction, pharmacokinetics (PK), safety and tolerability (including CV surveillance) of iptacopan in primary immunoglobulin A nephropathy (IgAN) pediatric patients aged 2 to \<18 years.
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
New hope for transplant patients: study aims to block dangerous late-stage virus
Disease control Recruiting nowThis study is being done to find out if administering CytoGam® after the end of standardly prescribed preventive antiviral treatment can help transplant recipients with a high risk for developing late CMV disease after a liver and/or kidney transplant.
Phase 4 • Sponsor: Camille N. Kotton, MD • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New pill could stop the maddening itch of prurigo nodularis
Symptom relief Recruiting nowEvaluate the efficacy and safety of ICP-332 in participants with Prurigo Nodularis (PN)
Phase 2 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New hope for Platinum-Resistant ovarian cancer?
Disease control Recruiting nowOvarian cancer (OC) is a lethal disease. The purpose of this study is to assess the safety, pharmacokinetics and efficacy of ABBV901, alone or in combination with bevacizumab, in participants with ovarian cancer. ABBV901 is an investigational drug for the treatment of ovarian ca…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New catheter aims to clear small brain clots in stroke patients
Disease control Recruiting nowProspective, Single-arm, Multi-centre Study to Evaluate the Efficacy and Safety of the iNstroke 4F Thromboaspiration Catheter in Patients with Acute Ischaemic Stroke due to Primary Distal Medium Vessel Occlusions.
Sponsor: iVascular S.L.U. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug MHB042C tested in advanced cancer patients
Disease control Recruiting nowThis is a first-in-human, open-label, multicenter Phase I/II study of MHB042C in patients with advanced solid tumors. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of MHB042C monotherapy.
Phase 1/2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New shot aims to tame bleeding disorder in small trial
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, pharmacokinetics (PK), and pharmacodynamic (PD) of SR604 in patients with von Willebrand disease.
Phase 2 • Sponsor: Shanghai RAAS Blood Products Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC